LTP NeuroMed is committed to finding novel therapeutics for CNS disorders with a focus on neurodegenerative diseases, primarily Alzheimer’s disease and epilepsy/dementia resulting from traumatic brain injury. 

We have established a portfolio of novel therapeutic candidates which we believe have potential to address unmet needs in the field of neurodegenerative diseases. Furthermore, we are striving to develop these candidates into differentiated therapeutic products that can make clinically meaningful differences in the quality of patients's lives.

We are actively seeking collaboration partners from both academia and biotech/pharmaceutical companies to advance these research projects.

​For interest and inquiry, please contact Dr. Li at

Shaping the Future of CNS Disorders